Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
- Products
-
- Duloxetine Delayed-Release Capsules
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 7389 bottles
- About this recall
- Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.